First National Bank of Omaha’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
46,685
+8,167
+21% +$1.76M 0.33% 79
2026
Q1
$8.33M Buy
38,518
+409
+1% +$90.7K 0.26% 103
2025
Q4
$8.72M Buy
38,109
+9,625
+34% +$2.19M 0.26% 100
2025
Q3
$6.6M Sell
28,484
-1,579
-5% -$322K 0.42% 65
2025
Q2
$5.58M Buy
30,063
+23,803
+380% +$4.42M 0.36% 78
2025
Q1
$1.31M Sell
6,260
-465
-7% -$90.4K 0.09% 213
2024
Q4
$1.2M Hold
6,725
0.08% 212
2024
Q3
$1.33M Sell
6,725
-1,015
-13% -$189K 0.08% 207
2024
Q2
$1.33M Buy
7,740
+1,480
+24% +$245K 0.09% 205
2024
Q1
$1.31M Sell
6,260
-2,080
-25% -$358K 0.09% 213
2023
Q4
$1.29M Sell
8,340
-120
-1% -$17.5K 0.08% 211
2023
Q3
$1.26M Buy
8,460
+620
+8% +$91K 0.08% 207
2023
Q2
$1.06M Sell
7,840
-355
-4% -$52.1K 0.06% 217
2023
Q1
$1.31M Sell
8,195
-339
-4% -$51.8K 0.08% 208
2022
Q4
$1.38M Sell
8,534
-3,008
-26% -$461K 0.09% 208
2022
Q3
$1.55M Buy
11,542
+1,103
+11% +$158K 0.1% 196
2022
Q2
$1.6M Buy
10,439
+237
+2% +$36.2K 0.1% 190
2022
Q1
$1.65M Sell
10,202
-924
-8% -$134K 0.08% 199
2021
Q4
$1.51M Buy
11,126
+1,354
+14% +$160K 0.07% 200
2021
Q3
$1.05M Sell
9,772
-5,733
-37% -$655K 0.05% 222
2021
Q2
$1.68M Hold
15,505
0.09% 188
2021
Q1
$1.68M Sell
15,505
-865
-5% -$92.5K 0.09% 188
2020
Q4
$1.75M Buy
16,370
+115
+0.7% +$11.1K 0.1% 180
2020
Q3
$1.42M Sell
16,255
-582
-3% -$54.8K 0.09% 174
2020
Q2
$1.65M Buy
16,837
+1,122
+7% +$98.8K 0.11% 162
2020
Q1
$1.2M Sell
15,715
-1,095
-7% -$93.3K 0.09% 171
2019
Q4
$1.49M Buy
16,810
+1,095
+7% +$90.9K 0.09% 188
2019
Q3
$1.19M Sell
15,715
-1,400
-8% -$96K 0.08% 197
2019
Q2
$1.24M Buy
17,115
+35
+0.2% +$2.75K 0.08% 191
2019
Q1
$1.38M Sell
17,080
-639
-4% -$52.3K 0.09% 182
2018
Q4
$1.63M Sell
17,719
-996
-5% -$87.6K 0.12% 170
2018
Q3
$1.77M Buy
18,715
+45
+0.2% +$4.27K 0.1% 227
2018
Q2
$1.73M Sell
18,670
-175
-0.9% -$17.1K 0.1% 230
2018
Q1
$1.78M Buy
18,845
+80
+0.4% +$8.79K 0.11% 222
2017
Q4
$1.81M Buy
18,765
+225
+1% +$21.2K 0.11% 216
2017
Q3
$1.65M Buy
18,540
+152
+0.8% +$11.6K 0.1% 220
2017
Q2
$1.33M Buy
18,388
+8
+0% +$538 0.08% 241
2017
Q1
$1.2M Sell
18,380
-440
-2% -$27.7K 0.07% 260
2016
Q4
$1.18M Sell
18,820
-200
-1% -$12.2K 0.07% 244
2016
Q3
$1.2M Sell
19,020
-268
-1% -$17.3K 0.09% 175
2016
Q2
$1.19M Sell
19,288
-1,382
-7% -$84.2K 0.09% 169
2016
Q1
$1.18M Buy
20,670
+75
+0.4% +$4.18K 0.09% 171
2015
Q4
$1.22K Sell
20,595
-1,150
-5% -$66.2K 0.09% 179
2015
Q3
$1.18K Sell
21,745
-565
-3% -$36.8K 0.09% 186
2015
Q2
$1.44K Hold
22,310
0.1% 181
2015
Q1
$1.44K Sell
22,310
-3,144
-12% -$190K 0.1% 181
2014
Q4
$1.67M Sell
25,454
-228
-0.9% -$14.4K 0.12% 177
2014
Q3
$1.48M Sell
25,682
-277
-1% -$15.4K 0.11% 183
2014
Q2
$1.47M Buy
25,959
+750
+3% +$39.3K 0.1% 185
2014
Q1
$1.3M Sell
25,209
-8,030
-24% -$406K 0.1% 183
2013
Q4
$1.76M Sell
33,239
-7,418
-18% -$365K 0.13% 165
2013
Q3
$1.82M Sell
40,657
-13,015
-24% -$577K 0.16% 153
2013
Q2
$2.22K Buy
+53,672
New +$2.35M 0.19% 144

Other funds holding ABBV

First National Bank of Omaha's ABBV Position: Q2 2026 in Review

First National Bank of Omaha increased its AbbVie (ABBV) stake by 21% in Q2 2026, buying an estimated $1.76M and bringing the position to 46,685 shares worth $11.8M. The position accounts for 0.33% of the portfolio, ranked #79.

First National Bank of Omaha first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First National Bank of Omaha held 46,685 shares of AbbVie worth $11.8M as of Q2 2026.
  • First National Bank of Omaha bought 8,167 AbbVie shares in Q2 2026, an estimated $1.76M.
  • AbbVie made up 0.33% of First National Bank of Omaha's portfolio in Q2 2026, its #79 holding.
  • First National Bank of Omaha first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First National Bank of Omaha's 13F filing for Q2 2026, filed 7 Aug 2026.